As of December 2024, Immuno-Biological Laboratories has a market cap of $27.51M. This makes Immuno-Biological Laboratories the world's 26805th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $28.78M | -3.04% |
2023 | $29.68M | 64.33% |
2022 | $18.06M | -11.76% |
2021 | $20.47M | -34.24% |
2020 | $31.13M | -24.42% |
2019 | $41.18M | 14.77% |
2018 | $35.88M | -21.16% |
2017 | $45.51M | -6.44% |
2016 | $48.64M | -21.02% |
2015 | $61.59M | -2.01% |
2014 | $62.85M | -22.15% |
2013 | $80.73M | 172.28% |
2012 | $29.65M | 10.80% |
2011 | $26.76M | 326.17% |
2010 | $6.28M | -14.51% |
2009 | $7.34M | 46.99% |
2008 | $5.00M | -81.80% |
2007 | $27.45M | - |